The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: Longitudinal quasi-experimental design
Amanj Baker, Li Chia Chen*, Rachel A. Elliott, Brian Godman
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
13Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: Longitudinal quasi-experimental design'. Together they form a unique fingerprint.